Effective heritable gene knockdown in zebrafish using synthetic microRNAs

Nature Communications

Volumn 6, Issue , 2015, Pages

  Giacomotto, Jean ^a   Rinkwitz, Silke ^a   Becker, Thomas S ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 155; MICRORNA 218; SURVIVAL MOTOR NEURON PROTEIN 1; SYNTHETIC MICRORNA; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; ZEBRAFISH PROTEIN;

CYPRINID; EXPERIMENTAL STUDY; GENE EXPRESSION; HERITABILITY; RNA;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ARTICLE; CELLULAR SECRETION; DISEASE SEVERITY; DOWN REGULATION; GENE EXPRESSION; GENE SILENCING; GENE TARGETING; HERITABILITY; HERITABLE GENE KNOCKDOWN; NONHUMAN; ONSET AGE; RNA SYNTHESIS; SPINAL MUSCULAR ATROPHY; TRANSGENICS; ZEBRA FISH; ANIMAL; GENETICS; TRANSGENIC ANIMAL;

DANIO RERIO;

3' UNTRANSLATED REGIONS; ANIMALS; ANIMALS, GENETICALLY MODIFIED; GENE KNOCKDOWN TECHNIQUES; MICRORNAS; ZEBRAFISH; ZEBRAFISH PROTEINS;

EID: 84930965780     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms8378     Document Type: Article

References (45)

1. Lieschke, G. J. & Currie, P. D. Animal models of human disease: zebrafish swim into view. Nat. Rev. Genet. 8, 353-367 (2007).
2. Giacomotto, J. & Segalat, L. High-throughput screening and small animal models, where are we? Br. J. Pharmacol. 160, 204-216 (2010).
3. Hwang, W. Y. et al. Efficient genome editing in zebrafish using a CRISPR-Cas system. Nat. Biotechnol. 31, 227-229 (2013).
4. Bedell, V. M. et al. In vivo genome editing using a high-efficiency TALEN system. Nature 491, 114-118 (2012).
5. Nasevicius, A. & Ekker, S. C. Effective targeted gene 'knockdown' in zebrafish. Nat. Genet. 26, 216-220 (2000).
6. Kok, F. O. et al. Reverse genetic screening reveals poor correlation between morpholino-induced and mutant phenotypes in zebrafish. Dev. Cell 32, 97-108 (2015).
7. Dong, M. et al. Heritable and lineage-specific gene knockdown in zebrafish embryo. PLoS ONE 4, e6125 (2009).
8. De Rienzo, G., Gutzman, J. H. & Sive, H. Efficient shRNA-mediated inhibition of gene expression in zebrafish. Zebrafish 9, 97-107 (2012).
9. Leong, I. U., Lan, C. C., Skinner, J. R., Shelling, A. N. & Love, D. R. In vivo testing of microRNA-mediated gene knockdown in zebrafish. J. Biomed. Biotechnol. 2012, 350352 (2012).
10. Zhao, X. F., Fjose, A., Larsen, N., Helvik, J. V. & Drivenes, O. Treatment with small interfering RNA affects the microRNA pathway and causes unspecific defects in zebrafish embryos. FEBS J. 275, 2177-2184 (2008).
11. Kelly, A. & Hurlstone, A. F. The use of RNAi technologies for gene knockdown in zebrafish. Brief Funct. Genomics 10, 189-196 (2011).
12. McBride, J. L. et al. Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: implications for the therapeutic development of RNAi. Proc. Natl Acad. Sci. USA 105, 5868-5873 (2008).
13. Zhao, Z., Cao, Y., Li, M. & Meng, A. Double-stranded RNA injection produces nonspecific defects in zebrafish. Dev. Biol. 229, 215-223 (2001).
14. Liu, W. Y. et al. Efficient RNA interference in zebrafish embryos using siRNA synthesized with SP6 RNA polymerase. Dev. Growth Differ. 47, 323-331 (2005).
15. Giraldez, A. J. et al. Zebrafish MiR-430 promotes deadenylation and clearance of maternal mRNAs. Science 312, 75-79 (2006).
16. Giraldez, A. J. et al. MicroRNAs regulate brain morphogenesis in zebrafish. Science 308, 833-838 (2005).
17. Premsrirut, P. K. et al. A rapid and scalable system for studying gene function in mice using conditional RNA interference. Cell 145, 145-158 (2011).
18. Dow, L. E. et al. A pipeline for the generation of shRNA transgenic mice. Nat. Protoc. 7, 374-393 (2012).
19. Lefebvre, S. et al. Identification and characterization of a spinal muscular atrophy-determining gene. Cell 80, 155-165 (1995).
20. Nicole, S., Diaz, C. C., Frugier, T. & Melki, J. Spinal muscular atrophy: recent advances and future prospects. Muscle Nerve 26, 4-13 (2002).
21. Burghes, A. H. & Beattie, C. E. Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick? Nat. Rev. Neurosci. 10, 597-609 (2009).
22. Boon, K. L. et al. Zebrafish survival motor neuron mutants exhibit presynaptic neuromuscular junction defects. Hum. Mol. Genet. 18, 3615-3625 (2009).
23. Hao le, T. et al. Temporal requirement for SMN in motoneuron development. Hum. Mol. Genet. 22, 2612-2625 (2013).
24. Hao le, T., Burghes, A. H. & Beattie, C. E. Generation and characterization of a genetic zebrafish model of SMA carrying the human SMN2 gene. Mol. Neurodegener. 6, 24 (2011).
25. Monani, U. R. et al. The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn(-/-) mice and results in a mouse with spinal muscular atrophy. Hum. Mol. Genet. 9, 333-339 (2000).
26. Hao le, T., Duy, P. Q., Jontes, J. D. & Beattie, C. E. Motoneuron development influences dorsal root ganglia survival and Schwann cell development in a vertebrate model of spinal muscular atrophy. Hum. Mol. Genet. 24, 346-360 (2015).
27. McWhorter, M. L., Monani, U. R., Burghes, A. H. & Beattie, C. E. Knockdown of the survival motor neuron (Smn) protein in zebrafish causes defects in motor axon outgrowth and pathfinding. J. Cell Biol. 162, 919-931 (2003).
28. Carrel, T. L. et al. Survival motor neuron function in motor axons is independent of functions required for small nuclear ribonucleoprotein biogenesis. J. Neurosci. 26, 11014-11022 (2006).
29. Kwan, K. M. et al. The Tol2kit: a multisite gateway-based construction kit for Tol2 transposon transgenesis constructs. Dev. Dyn. 236, 3088-3099 (2007).
30. Chung, K. H. et al. Polycistronic RNA polymerase II expression vectors for RNA interference based on BIC/miR-155. Nucleic Acids Res. 34, e53 (2006).
31. Punnamoottil, B., Rinkwitz, S., Giacomotto, J., Svahn, A. J. & Becker, T. S. Motor neuron-expressed microRNAs 218 and their enhancers are nested within introns of SLIT2/3 genes. Genesis doi:10.1002/dvg.22852 (2015).
32. Lewis, K. E. & Eisen, J. S. From cells to circuits: development of the zebrafish spinal cord. Prog. Neurobiol. 69, 419-449 (2003).
33. Dow, L. E. et al. A pipeline for the generation of shRNA transgenic mice. Nat. Protoc. 7, 374-393 (2012).
34. Tews, B. et al. Synthetic microRNA-mediated downregulation of Nogo-A in transgenic rats reveals its role as regulator of synaptic plasticity and cognitive function. Proc. Natl Acad. Sci. USA 110, 6583-6588 (2013).
35. Giacomotto, J. et al. Chemical genetics unveils a key role of mitochondrial dynamics, cytochrome c release and IP3R activity in muscular dystrophy. Hum. Mol. Genet. 22, 4562-4578 (2013).
36. Shinya, M. et al. Properties of gene knockdown system by vector-based siRNA in zebrafish. Dev Growth Differ. 55, 755-765 (2013).
37. Dong, Z., Peng, J. & Guo, S. Stable gene silencing in zebrafish with spatiotemporally targetable RNA interference. Genetics 193, 1065-1071 (2013).
38. Ashburn, T. T. & Thor, K. B. Drug repositioning: identifying and developing new uses for existing drugs. Nat. Rev. Drug Discov. 3, 673-683 (2004).
39. Weinstein, J. N. Pharmacogenomics - teaching old drugs new tricks. N. Engl. J. Med. 343, 1408-1409 (2000).
40. Li, D. K. et al. A cell system for phenotypic screening of modifiers of SMN2 gene expression and function. PLoS ONE 8, e71965 (2013).
41. Giacomotto, J., Segalat, L., Carre-Pierrat, M. & Gieseler, K. Caenorhabditis elegans as a chemical screening tool for the study o f neuromuscular disorders. Manual and semi-automated methods. Methods 56, 103-113 (2012).
42. Rihel, J. et al. Zebrafish behavioral profiling links drugs to biological targets and rest/wake regulation. Science 327, 348-351 (2010).
43. Teng, X. et al. Genome-wide consequences of deleting any single gene. Mol. Cell. 52, 485-494 (2013).
44. Becker, T. S. & Rinkwitz, S. Zebrafish as a genomics model for human neurological and polygenic disorders. Dev. Neurobiol. 72, 415-428 (2012).
45. Djiotsa, J. et al. Pax4 is not essential for beta-cell differentiation in zebrafish embryos but modulates alpha-cell generation by repressing arx gene expression. BMC Dev. Biol. 12, 37 (2012).